Bavarian Nordic AS (BAVA) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Date: May 15, 2015
Pages: 33
Price:
US$ 250.00
License [?]:
Publisher: GlobalData
Report type: Strategic Report
Delivery: E-mail Delivery (PDF)
ID: B54B45959F1EN
Leaflet:

Download PDF Leaflet

Bavarian Nordic AS (BAVA) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
Summary

Bavarian Nordic A/S (Bavarian Nordic) is a biotechnology company. It is involved in developing product candidates to address cancer and infectious diseases. The company utilizes its technology platforms MVA-BN and VF-TRICOM to develop a wide range of products in the areas of cancer and infectious diseases. Its cancer pipeline product portfolio targets various types of cancers such as bladder and breast cancer among others. The company’s products find application in the treatment of diseases such as smallpox, prostate cancer, anthrax, breast cancer, marburg and ebola infections, among others. It also develops viral vaccines for research, clinical and commercial applications. The company owns and operates a manufacturing facility in Kvistgaard, Denmark. Bavarian Nordic is headquartered in Kvistgaard, Denmark.

Bavarian Nordic AS (BAVA) - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope
  • Financial Deals - Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
  • Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
  • Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
  • Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
  • Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
  • Major Deals - Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
  • Business Description - A brief description of the company's operations.
  • Key Employees - A list of the key executives of the company.
  • Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
  • Key Competitors - A list of the key competitors of the company.
  • Key Recent Developments - A brief on recent news about the company.
Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements - The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy - The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company - Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers. - The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company - Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research - Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company.
Bavarian Nordic A/S, Pharmaceuticals & Healthcare, Deals By Year, 2009 to YTD 2015
Bavarian Nordic A/S, Pharmaceuticals & Healthcare Deals By Type, 2009 to YTD 2015
Bavarian Nordic A/S, Pharmaceuticals & Healthcare, Deals By Region, 2009 to YTD 2015
Bavarian Nordic A/S, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2009 to YTD 2015
Bavarian Nordic A/S, Pharmaceuticals & Healthcare, Deals Summary, 2009 to YTD 2015
Bavarian Nordic A/S, Pharmaceuticals & Healthcare, Deal Details
Asset Purchase
Bavarian Nordic Acquires Patent Rights Of MVA-BN-HER2 From Pharmexa
Partnerships
Bavarian Nordic Enters Into Collaboration With University of Copenhagen And Statens Serum Institut
Licensing Agreements
Bristol-Myers Squibb Enters into Option for Licensing Agreement with Bavarian Nordic
Bavarian Nordic Enters into Licensing Agreement with Crucell Holland
Bavarian Nordic Receives Proposals To License Prostvac
Bavarian Nordic Enters Into Licensing Agreement With Oxford BioMedica
Oxford BioMedica Enters Into Licensing Agreement With Bavarian Nordic
Equity Offering
Bavarian Nordic Raises USD1.7 Million in Private Placement of Shares upon Exercise of Warrants
Bavarian Nordic Raises USD1 Million upon Exercise of Warrants
Bavarian Nordic Raises USD1 Million upon Exercise of Warrants
Bavarian Nordic Raises USD43 Million in Private Placement of Shares
Bavarian Nordic Raises USD3.8 Million in Private Placement of Shares upon Exercise of Warrants
Bavarian Nordic Completes Rights Issue Of US$132 Million
Bavarian Nordic Completes Private Placement Of US$36 Million
Bavarian Nordic Completes Rights Offering Of US$64 Million
Acquisition
Bavarian Nordic Acquires Remaining Stake In BN ImmunoTherapeutics
Bavarian Nordic A/S - Key Competitors
Key Employees
Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Appendix
Methodology
About GlobalData
Contact Us
Disclaimer

LIST OF TABLES
Bavarian Nordic A/S, Pharmaceuticals & Healthcare, Key Facts, 2014
Bavarian Nordic A/S, Pharmaceuticals & Healthcare, Deals By Year, 2009 to YTD 2015
Bavarian Nordic A/S, Pharmaceuticals & Healthcare Deals By Type, 2009 to YTD 2015
Bavarian Nordic A/S, Pharmaceuticals & Healthcare, Deals By Region, 2009 to YTD 2015
Bavarian Nordic A/S, Deals By Therapy Area, 2009 to YTD 2015
Bavarian Nordic A/S, Pharmaceuticals & Healthcare, Deals Summary, 2009 to YTD 2015
Bavarian Nordic Acquires Patent Rights Of MVA-BN-HER2 From Pharmexa
Bavarian Nordic Enters Into Collaboration With University of Copenhagen And Statens Serum Institut
Bristol-Myers Squibb Enters into Option for Licensing Agreement with Bavarian Nordic
Bavarian Nordic Enters into Licensing Agreement with Crucell Holland
Bavarian Nordic Receives Proposals To License Prostvac
Bavarian Nordic Enters Into Licensing Agreement With Oxford BioMedica
Oxford BioMedica Enters Into Licensing Agreement With Bavarian Nordic
Bavarian Nordic Raises USD1.7 Million in Private Placement of Shares upon Exercise of Warrants
Bavarian Nordic Raises USD1 Million upon Exercise of Warrants
Bavarian Nordic Raises USD1 Million upon Exercise of Warrants
Bavarian Nordic Raises USD43 Million in Private Placement of Shares
Bavarian Nordic Raises USD3.8 Million in Private Placement of Shares upon Exercise of Warrants
Bavarian Nordic Completes Rights Issue Of US$132 Million
Bavarian Nordic Completes Private Placement Of US$36 Million
Bavarian Nordic Completes Rights Offering Of US$64 Million
Bavarian Nordic Acquires Remaining Stake In BN ImmunoTherapeutics
Bavarian Nordic A/S, Key Competitors
Bavarian Nordic A/S, Key Employees
Bavarian Nordic A/S, Other Locations
Bavarian Nordic A/S, Subsidiaries

LIST OF FIGURES
Bavarian Nordic A/S, Pharmaceuticals & Healthcare, Deals by Type, 2009 to YTD 2015
Bavarian Nordic A/S, Pharmaceuticals & Healthcare, Deals By Year, 2009 to YTD 2015
Bavarian Nordic A/S, Pharmaceuticals & Healthcare, Deals By Region, 2009 to YTD 2015
Bavarian Nordic A/S, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2009 to YTD 2015
Bavarian Nordic A/S, Pharmaceuticals & Healthcare, Deals By Year, 2009 to YTD 2015
Bavarian Nordic A/S, Pharmaceuticals & Healthcare, Deals by Type, 2009 to YTD 2015
Bavarian Nordic A/S, Pharmaceuticals & Healthcare, Deals By Region, 2009 to YTD 2015
Bavarian Nordic A/S, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2009 to YTD 2015
Skip to top


Ask Your Question

Bavarian Nordic AS (BAVA) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
Company name*:
Contact person*:
Phone/fax*:
Email*:
Request invoice
Your enquiry:
Please click on a Check Box below to confirm you are not a robot: